Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Published: 23.11.2022 Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Published: 20.10.2022 Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Published: 04.08.2022 Navamedic ASA acquires Impolin AB and bolsters its product portfolio Published: 05.05.2022 Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Published: 16.02.2022 Treating the side-effects of the pandemic Published: 24.06.2021 FirstPrevious12345NextLast
Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Published: 23.11.2022
Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Published: 20.10.2022
Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Published: 04.08.2022
Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Published: 16.02.2022